Select Committee on Health Minutes of Evidence



  410.  The following list is not exhaustive:

    —  Fudenburg, H H, Dialysable lymphocyte extract in infantile onset autism; a pilot study, Biotherapy, 1996, 9, 143-7.

    —  Iannetti P et al, Immunisations and brain damage, Pediatr Oggi Med Chir 14/3-4 (31-136), 1994.

    —  Schwartz, R, Advances in clinical immunology, Practitioner, October 1967, p 514 onwards.

    —  Sabra, Bellanti, Colon, International Centre for Interdisciplinary Studies of Immunology, Georgetown University Medical Centre, letter, Lancet, July 1998.

    —  Takashi Fujinaga et al, a prefecture-wide survey of mumps meningitis associated with MMR vaccine, Paediatric Infectious Disease Journal (R), March 1991.

    —  Halsey et al, Increased mortality after high titer measles vaccine, Paediatric Infectious Disease Journal (R), June 1993.

    —  Odent, M. Long term effects of early vaccinations, Primal Health Research Vol 2, no 1, p 6, Summer 1994.

    —  Singh et al, Antibodies to myelin basic protein in children with autistic behaviour, Singh et al, Brain, Behaviour and Immunity, vol 7, pp 97-103 (1993).

    —  Farrington et al, A new method for active surveillance of adverse events, Lancet, Vol 345, pp 567-9.

    —  Thompson P et al, Is measles vaccination a risk factor for inflammatory bowel disease?, Lancet, Vol 345, pp 1071-4, April 1995.

    —  Warren R et al, Decreased plasma concentrations of the C4B complement protein in autism, Archives of Pediatrics and Adolescent Medicine, vol 148, 180-3, February 1994.

    —  Montinari et al, Role of Immunogenetics in the Diagnosis of Past-vaccinal CNS Pathology, Department of Pediatric Surgery, University of Bari, paper presented May 1996.

    —  Etiology of infantile autism: a review of recent advances in genetic and neurobiological research, Journal of Psychiatry and Neuroscience, Vol 24, no 2, March 1999, pp 103-15.

    —  Anemia of a mild viral infection (using) the measles vaccine as a model, Pediatrics, Vol 84, no 5, November 1989, pp 851-5.

    —  Acute encepalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program, Pediatrics, Vol 101, no 3, Part 1, March 1998, pp 383-7.

    —  Laitinen et al, Very high measles and rubella virus antibody titers associated with hepatitis, systemic lupus erythematosus and infectious mononucleosis, Lancet, vol 1, February 1974, pp 194-7.

    —  Serum autoantibodies to brain in Landau-Kleffner variant, autism and other neurologic disorders, Journal of Pediatrics, vol 134. No 5, May 1999, pp 607-613.

    —  Bacterial translocation from the gastrointestinal tract, Trends in Microbiology, Vol 3, no 4, pp. 149-54, April 1995.

    —  Paramyxovirus infections in childhood and subsequent inflammatory bowel disease, Gastroenterology, Vol 116, no 4, pp 796-803, April 1999.

    —  D'Eufemia et al, Abnormal intestinal permeability in children with autism, Acta Pediatrica 85, 1076-9, 1996.

    —  Singh, V, Plasma increase of interleukin-12 and interferon-gamma: pathological significance in autism, Journal of Neuroimmunology, 2915 1996).

    —  Gupta, S, Immunology and immunological treatment of autism, conference paper, University of California.

    —  Gupta et al, Dysregulated immune system in children with autism, beneficial effects of intravenous immune globulin on autistic characteristics, Journal of Autism and Development Disorders, Vol 26, no 4, 1996.

    —  O'Behan, P, Acute disseminated encephalomyelitis, factsheet, Glasgow University.

    —  Murch, S et al, autism, inflammatory bowel disease and MMR vaccine, letter, Lancet, 1998, 351, 908.

    —  Wakefield, A J et al, Ileal lymphoid nodular hyperplasia, non-specific colitis and pervasive developmental disorder in children, Lancet, 1998, 351, 637-41.

    —  Wakefield, A J, autism, inflammatory bowel disease and MMR vaccine, letter, Lancet, 1998, 351, 908.

    —  Bolte, E, Autism and clostridium tetani, Medical Hypotheses, vol 51, 1998, pp 133-44.

    —  Wakefield, A J, Autism, inflammatory bowel disease and MMR vaccine, letter, Lancet, 1998, 351, 1356.

    —  Zecca et al, Elevated rubeola titers in autistic children linked to MMR vaccine, abstract submitted to the National Institutes of Health, 1997-8.

    —  Walker-Smith, J A, Autism, inflammatory bowel disease and MMR vaccine, letter, Lancet, 1998, 351, 1356-7.

    —  Singh et al, Serological association of measles virus, Clinical Immunology and Immunopathology, 1998, 89(1), 105-8.

previous page contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries

© Parliamentary copyright 1999
Prepared 27 July 1999